Stoke Therapeutics, Inc. earnings per share and revenue

STOK earnings per share for the last quarter are -0.47 USD whereas the estimation was -0.52 USD which accounts for 9.62% surprise. Company revenue for the same period amounts to 4.89 M USD despite the estimated figure of 3.83 M USD. Estimated earnings per share for the next quarter are -0.54 USD, and revenue is expected to reach 4.20 M USD. Also watch annual changes over time to get a bigger picture of STOK earnings per share and revenue dynamics.